COVID-19: CADD to the rescue

Abdulmujeeb T Onawole1, Kazeem O Sulaiman2, Temitope U Kolapo3

  • 1Department of Chemistry, King Fahd University of Petroleum and Minerals, Dhahran, 31261 Saudi Arabia.

Virus Research
|May 18, 2020
PubMed

Insights

Researchers screened 44 million compounds using virtual screening to find potential COVID-19 treatments. Three promising compounds were identified that could inhibit the virus

Area of Science:

  • Drug Discovery
  • Computational Chemistry
  • Virology

Background:

  • The COVID-19 pandemic, caused by SARS-CoV-2, represents a significant global health emergency.
  • There is an urgent need for effective antiviral drugs to combat the spread and fatalities associated with the disease.

Purpose of the Study:

  • To identify novel compounds with the potential to inhibit SARS-CoV-2 entry and replication.
  • To utilize computational methods for efficient drug candidate screening.

Main Methods:

  • Employed virtual screening of a large compound database (44 million molecules).
  • Focused on identifying inhibitors of the viral surface glycoprotein essential for host cell entry.
  • Utilized a consensus scoring approach to evaluate compound efficacy and properties.

Main Results:

  • Identified three lead compounds exhibiting promising physicochemical characteristics.
  • These compounds demonstrated favorable molecular interactions with the target viral protein.
  • The selected compounds show potential for further development into COVID-19 therapeutics.

Conclusions:

  • Virtual screening is an effective strategy for discovering potential SARS-CoV-2 inhibitors.
  • The identified compounds warrant further investigation and lead optimization for drug development.
  • This study contributes to the ongoing efforts to find treatments for COVID-19.